Oft, Martin

IL-23 promotes tumour incidence and growth

Langowski, J. L., Zhang, X., Wu, L., Mattson, J. D., Chen, T., Smith, K., Basham, B., McClanahan, T., Kastelein, R. A., & Oft, M. (2006) · Nature

Immune cells in cancerCytokine Signaling Pathways and Interactions

Cited by 1,018

IL-10 Elicits IFNγ-Dependent Tumor Immune Surveillance

Mumm, J. B., Emmerich, J., Zhang, X., Chan, I., Wu, L., Mauze, S., Blaisdell, S., Basham, B., Dai, J., Grein, J., et al. (2011) · Cancer Cell

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses

Cited by 418

IL-10: Master Switch from Tumor-Promoting Inflammation to Antitumor Immunity

Oft, M. (2014) · Cancer Immunology Research

T-cell and B-cell ImmunologyCancer Immunotherapy and Biomarkers

Cited by 322

TGF-β inhibits p70 S6 kinase via protein phosphatase 2A to induce G1 arrest

Petritsch, C., Beug, H., Balmain, A., & Oft, M. (2000) · Genes & Development

TGF-β signaling in diseasesPI3K/AKT/mTOR signaling in cancer

Cited by 223

Pegylated IL‐10 induces cancer immunity: The surprising role of IL‐10 as a potent inducer of IFN‐γ‐mediated CD8+ T cell cytotoxicity

Mumm, J. B., & Oft, M. (2013) · BioEssays

Immunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers

Cited by 53